I'm expecting a slight treeshake before close as the MMs look for cheap stock to fill a large background buy order.
GLA LTHers! |
eva198919 Dec '22 - 10:14 - 38420 of 38780
0 1 0
Booked decent loss
Heartbreaking but I'm now done with IMM.
Onto Destiny Pharma now
----
halfbutt19 Dec '22 - 19:19 - 38421 of 38780
0 1 0
Me too eva... hope you still have hammersmith xxx
------
lord loads of lolly19 Dec '22 - 19:21 - 38422 of 38780
0 0 2
Eva Perone - I fear your destiny is less pharma. More the cappuccino maker.
----- |
I'm in this -
Taken a few earlier -
It may be nothing however you cannot lie about the title -
If so then the company are in big trouble or we will go a lot further - |
"The Company is not at this time releasing detailed data as these findings form part of the ongoing expansion of our intellectual property portfolio including additional patents for P140."
Once the do then whoosh!
GLA LTHers! |
Mcap below 10mcap is crazy when looking you consider that according to SNS Insider, The Global Autoimmune Disease Therapeutics Market was valued at USD 72.34 Billion in 2023 and is projected to reach USD 116.81 Billion by 2032, growing at a compound annual growth rate (CAGR) of 5.52% from 2024 to 2032." From 13 Dec 2024 |
Nah classy outfit and industry more like, not some two bob Ausi miner bs-ing about diamonds and Gold,
Partners and premium is the landscape |
A stall prior was good. A good start - so it will come and hopefully sticks |
has to hit at least 118% (top end 166%) before the news can truly be assessed (hold or sell) |
Misleading is the share price rise here, it's not 98% cos yesterday buy price was 1.35 ish, so more 75% so far |
Well hopefully people get a positive surprise here, sphere25. It is certainly a non consensual call and at £8m valuation would come as a surprise to most. But I objectively think it has a lot going for it. GLA |
Ah, I remember now. Old lollywally bought 2/3 years ago at some multiple of todays price. And since then he has commentated, and postured, and spat out his dummy over and over. But what you'll never find lollywally doing is committing to a decision - is he now buying/selling/holding? Quite ironic for a poster who repeatedly chides the management capabilities of others |
Do you know when you go through the feed in the morning...and see an RNS like this...
"Immupharma PLC Breakthrough Findings into Autoimmune Diseases"
The eyes light up and you're sat there thinking...
"Wow! Maybe one of our tiddlers is about to set the market alight and provide some overdue euphoria. Almost anybody could trade on that and generate a return"
And then...
You read it and you're like...
"Hang on...what? I thought this was supposed to be some MEGA news. I mean, have they found a midget gem behind the sofa?"
So is this just a pump before a cash raise?
In the Land of De-Listing's, still sat waiting for those days when the odd few set the market on fire and go absolutely rocket ape...bananana....rama.
Those days when there used to be hundreds and hundreds of posts a day on a single forum.
Surely something out there is going to surprise amongst the majority of de-listings to come.
Surely? |
Also, I believe chairman TM marched this tiny uk biotech all the way to completion of a phase 3 in a blockbuster indication. Not too bad then. |
I recall you had an investment here, lordlolly. Are you still invested? |
This dog will drop I am with Nobby....! Nothing RNS & will be dumped into.... |
All very well saying don't judge a share through the rear view mirror.
However, barring a Board shakeup, that's often the only real indicator of a Director's track record. TM has a proud history of marching shareholders up to the top of the hill and marching them down again.
This RNS has all the hallmarks of Tim's usual puffery. Create excitement, make it sound like you're on the cusp of something huge, then reveal a hitch, followed by radio silence for another eternity. Look at Incanthera if you don't believe me. |
I'm already in Wig -
I think there will be patents coming to fruition here for the data they have -
It be interesting to see how they use this data because clearly they are not saying anything at the moment - |
Depends who has it tomboy, and for what purpose |
"But Nobby may well be right." The market cap is £8m, and if nobs consensual view is right you might lose some money, tomboy. But the key thing to consider from this valuation is - what happens to the share price if he is wrong... ATB |
Wig nothing wrong with having Pharmacological knowledge - |
Its Generic and not specific I think to P140 but there may well be patents on the way -
Gotta dash but if there is anything of what their title says then it could well be a beast - |
For the record, I couldn't care less about nobs scientific analysis. There was an opportunity to ride a multi bagger here prior to the last phase 3 readout, and along with many others I took it. But nob did not take it. This is an investment board. If you want plaudits for science, look elsewhere. |
I was just going to ask your opinion Nobby -
IMM have data correlating to auto-immune mechanisms. And will be increasing a number of patents for P140.
I presume this is specific to P140 not generic (although it sounds it) -
No release of data due to patent pending? - |
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
